Clinical trial · Interventional
Spectral CT Clinical Trial
NCT05361356CI-TRIAL-00065408terminatedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Investigational product had been released in NMPA, Sponsor decided to terminate the study aligned with investigator.
Summary
Brief summary (as posted)
The objective of this clinical trial was to evaluate the efficacy, ease of operation, stability, and safety of Spectral CT as expected.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Adult ALL | Adult Acute Lymphoblastic Leukemia | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Spectral CT scanning | Radiation | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Experimental group, all volunteer will be scanned.
- description
- All participation accept Spectral CT scanning; No group;
- interventionNames
- Radiation: Spectral CT scanning
Primary outcomes (1)
- measure
- Excellent and good rate of clinical imaging (score≥3）
- timeFrame
- through study completion, an average of 1 year
- description
- Rated items 5 points Excellent image quality for diagnostic purposes, very satisfactory 4 points good image quality, can be used for diagnosis, satisfactory 3 points Image quality defects, do not affect the diagnosis, general 2. Unsatisfactory image quality, affecting diagnosis Poor image quality, undiagnosable, unsatisfactory
Secondary outcomes (4)
- measure
- Common functions assessment
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * Volunteers (ages 18 to 75); * Negative pregnancy tests for women of childbearing age; * Agree to participate in the clinical trial and sign the subject informed consent form; * Enhanced scan requires laboratory evidence of normal renal function. Exclusion Criteria: * The body cannot comply with CT examination; * Pregnant and lactating women; * Claustrophobia; * People who are not suitable for enhanced scanning with iodine contrast agent (previous severe heart failure and hyperthyroidism, iodine contrast agent allergy and susceptibility); * Patients deemed unsuitable for participation in this clinical trial by the investigator.
References
Publications (0)
Data not yet available
No reference posted for this study.